Original Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. May 7, 2009; 15(17): 2097-2108
Published online May 7, 2009. doi: 10.3748/wjg.15.2097
Figure 4
Figure 4 CSE expression/activity is regulated with an FXR ligand in vivo. A: FXR +/+ and FXR -/- mice were treated for 3 d with vehicle or with 6E-CDCA 5 mg/kg body weight. Total RNA from liver of FXR +/+ and FXR -/- mice was subjected to real-time PCR quantification of CSE gene expression. aP < 0.05 versus FXR +/+ control mice; B: FXR +/+ and FXR -/- mice were treated for three days with vehicle or with 6E-CDCA 5 mg/kg body weight. Livers from FXR +/+ and FXR -/- mice were homogenized in cold PBS to evaluate CSE activity. aP < 0.05 versus FXR +/+ control mice. cP < 0.05 versus FXR -/- control mice; C: FXR +/+ and FXR -/- mice were treated for 3 d with vehicle or with 6E-CDCA 5 mg/kg body weight. Livers from FXR +/+ and FXR -/- mice were homogenized in cold PBS to evaluate H2S production. aP < 0.05 versus FXR +/+ control mice. Data represent the mean ± SD of six experiments.